2016
研究業績
Papers (English)
Original papers
1. Hamaguchi T, Taniguchi Y, Sakai K, Kitamoto T, Takao M, Murayama S,
Iwasaki Y, Yoshida M, Shimizu H, Kakita A, Takahashi H, Suzuki H, Naiki
H, Sanjo N, Mizusawa H, Yamada M. Significant association of cadaveric
dura mater grafting with subpial Aβ deposition and meningeal amyloid
angiopathy. Acta Neuropathol 132:313-315, 2016✳
✳Press release from Kanazawa University
(https://www.kanazawa-u.ac.jp/wp-content/uploads/2016/06/160617.pdf)
2. Ikeda T, Yoshizawa K, Takahashi K, Ishida C, Komai K, Kobayashi K, Sugiura S. Effectiveness of electric toothbrushing in patients with neuromuscular disability: A randomized observer-blind crossover trial. Spec Care Dentist 36:13-17, 2016
3. Ito M, Nakamura K, Mori F, Miki Y, Tanji K, Wakabayashi K. Novel eosinophilic neuronal cytoplasmic inclusions in the external cuneate nucleus of humans. Neuropathology 36:441-447, 2016
4. Iwasa K, Furukawa Y, Yoshikawa H, Yamada M. Caveolin-3 is aberrantly expressed in skeletal muscle cells in myasthenia gravis. J Neuroimmunol 301:30-34, 2016
5. Kobayashi A, Matsuura Y, Iwaki T, Iwasaki Y, Yoshida M, Takahashi H, Murayama S, Takao M, Kato S, Yamada M, Mohri S, Kitamoto T. Sporadic Creutzfeldt-Jakob disease MM1+2 and MM1 are identical in transmission properties. Brain Pathol 26:95-101, 2016
6. Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobágyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kövari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemüller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White III CL, Wisniewski T, Woulfe JM, Yamada M, Dickson DW. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87-102, 2016
7. McKeith I, Boeve B, Dickson D, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard C, Bayston A, Beach T, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda J, El-Agnaf O, Feldman H, Ferman T, Ffytche D, Fujishiro H, Galasko D, Graff-Radford N, Goldman J, Gomperts S, Honing L, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee V, Leverenz J, Lippa C, Lewis S, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine T, Moreno E, Mori E, Murray M, O’Brien J, Orimo S, MD; Postuma R, Ramaswamy S, Ross O, Salmon D, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo J, Trojanowski J, Tsuang D, Walker Z, Yamada M, Kosaka K. Recommendations for the diagnosis and management of dementia with Lewy bodies. Fourth report of the DLB consortium. Neurology (In Press)
8. Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LPC, Gambetti P, Blevins J, Zhang S, Cohen Y, Chen W, Yamada M, Hamaguchi T, Sanjo N, Mizusawa H, Nakamura Y, Kitamoto T, Collins SJ, Boyd A, Will RG, Knight R, Ponto C, Zerr I, Kraus TFJ, Eigenbrod S, Giese A, Calero M, de Pedro-Cuesta J, Haïk S, Laplanche JL, Bouaziz-Amar E, Brandel JP, Capellari S, Parchi P, Poleggi A, Ladogana A, O’Donnell-Luria AH, Karczewski KJ, Marshall JL, Boehnke M, Laakso M, Mohlke KL, Kähler A, Chambert K, McCarroll S, Sullivan PF, Hultman CM, Purcell SM, Sklar P, van der Lee SJ, Rozemuller A, Jansen C, Hofman A, Kraaij R, van Rooij JGJ, Ikram MA, Uitterlinden AG, van Duijn CM, Exome Aggregation Consortium (ExAC), Daly MJ, MacArthur DG. Quantifying penetrance in a dominant disease gene using large population control cohorts. Sci Transl Med 8:322ra9, 2016
9. Nakamura K, Hamaguchi T, Sakai K, Noto D, Ono K, Hayashi Y, Nishino I, Yamada M. Granuloma formation in a patient with GNE myopathy: a case report. Neuromuscul Disord (In Press)
10. Nakamura K, Hamaguchi T, Yamada M. Demyelinating polyneuropathy after long-term treatment with infliximab. Int J Rheum Dis (In Press)
11. Nakamura K, Mori F, Kon T, Tanji K, Miki Y, Tomiyama M, Kurotaki H, Toyoshima Y, Kakita A, Takahashi H, Yamada M, Wakabayashi K. Accumulation of phosphorylated α-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration. Neuropathology 36:157-167, 2016
12. Nakamura K, Mori F, Tanji K, Miki Y, Toyoshima Y, Kakita A, Takahashi H, Yamada M, Wakabayashi K. α-Synuclein pathology in the cranial and spinal nerves in Lewy body disease. Neuropathology 36:262-269, 2016
13. Nakano H, Yanase D, Mae K, Toribatake Y, Yamada M. Succesful antibacterial therapy of a spinal epidural abscess in pregnancy: a case report and review of the literature. J Neurol Sci (In Press)
14. Nakano H, Yanase D, Yamada M. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with lateral medullary syndrome: case report and literature review. BMC Neurol 16:119, 2016
15. Noguchi-Shinohara M, Komatsu J, Samuraki M, Matsunari I, Ikeda T, Sakai K, Hamaguchi T, Ono K, Nakamura H, Yamada M. Cerebral amyloid angiopathy-related microbleeds and CSF biomarkers in Alzheimer’s disease. J Alzheimers Dis (In Press)
16. Samuraki M, Sakai K, Odake Y, Yoshita M, Misaki K, Nakada M, Yamada M. Multiple sclerosis showing elevation of adenosine deaminase levels in the cerebrospinal fluid. Mult Scler Relat Dis (In Press)
17. Shima K, Iwasa K, Yoshita M, Yamada M. Vernet’s syndrome induced by internal jugular vein thrombosis. J Neurol Neurosurg Psychiatry 87:1252-1253, 2016
18. Shimazaki C, Fuchida S-I, Suzuki K, Ishida T, Imai H, Sawamura M, Takamatsu H, Abe M, Miyamoto T, Hata H, Yamada M, Ando Y. Phase 1 study of bortezomib in combination with melphalan and dexamethsone in Japanese patients with relapsed AL amyloidosis. Int J Hematol 103:79-85, 2016
19. Shimizu T, Ishikawa-Takata K, Sakata A, Nagaoka U, Ishihara N, Ishida C, Nakayama Y, Komori T, Nishizawa M. The measurement and estimation of total energy expenditure in Japanese patients with ALS: a doubly labeled water method study. Amyotroph Lateral Scler Frontotemporal Degener（In Press）
20. Takahashi K, Kakuda Y, Munemoto S, Yamazaki H, Nozaki I, Yamada M. Long-lived human tissue-resident macrophages in the central nervous system. Clin Exp Neuroimmunol 7:286-287, 2016
21. Takeuchi A, Kobayashi A, Parchi P, Yamada M, Morita M, Uno S, Kitamoto T. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification. Lab Invest 96:581-587, 2016
22. Tugcu A, Jin Z, Homma S, Elkind MS, Rundek T, Yoshita M, DeCarli C, Nakanishi K, Shames S, Wright CB, Sacco RL, Di Tullio MR. Atherosclerotic plaques in the aortic arch and subclinical cerebrovascular disease. Stroke 47:2813-2819, 2016
23. Umeda T, Ono K, Klein WL, Yamada M, Mori H, Tomiyama T. Rifampicin is a candidate preventive medicine against amyloid β and tau oligomers. Brain 139:1568-1586, 2016
24.
Watanabe-Nakayama T*, Ono K*, Itami M, Takahashi R, Teplow DB, Yamada M.
High-speed atomic force microscopy reveals structural dynamics of
amyloid β1-42 aggregates. Proc Natl Acad Sci USA 113:5835-5840, 2016✳✳
*equally contributed
✳✳Press release from Kanazawa University
(https://www.kanazawa-u.ac.jp/wp-content/uploads/2016/05/160510.pdf)
25. Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E,Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR; MGTX Study Group. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375:511-522, 2016
26. Wright CB, Shah NH, Mendez AJ, DeRosa JT, Yoshita M, Elkind MS, Sacco RL, DeCarli C, Rundek T, Silverberg S, Dong C, Wolf M. Fibroblast growth factor 23 is associated with subclinical cerebrovascular damage: The Northern Manhattan Study. Stroke 47:923-928, 2016
27. Zekonyte J, Sakai K, Nicoll JA, Weller RO, Carare RO. Quantification of molecular interactions between apoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer’s disease. Biochim Biophys Acta 1862:1047-1053, 2016
Reviews
1. Frontzek K, Budkan H, Diamond M, Yamada M, Selkoe D. Ask the experts: Is Alzheimer’s disease transmissible? Part 1, Part 2, and Part 3. Neurology Central July 7-9, 2016
2. Kobayashi A, Parchi P, Yamada M, Mohri S, Kitamoto T. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases. Neuropathology 236:305-310, 2016
3. Takamori M. Structure and function of neuromuscular junction, centered on muscle-specific tyrosine kinase and related proteins. Olin Exp Neuroimmunol 7:215-225, 2016
4. Nakajima K, Yamada M. 123I-Meta-iodobenzylguanidine sympathetic imaging: standardization and application to neurological diseases. Chonnam Med J 52:145-150, 2016
Invited lectures
1. Yamada M. Natural phenolic compounds as therapeutic and preventive agents for Alzheimer’s disease. Seminar in Neurosciences, UCSD, San Diego, April 4, 2016
2. Yamada M, Hamaguchi T, Sakai K, Nozaki I, Shinohara M, Sanjo N, Tsukamoto T, Ae R, Nakamura Y, Kitamoto T, Mizusawa H, CJD Surveillance Committee, Japan. Epidemiological and clinical features of human prion diseases in Japan: Prospective 17-year surveillance. PRION 2016, Tokyo, May 10-13, 2016
3. Yamada M. From prion disease to Alzheimer’s disease. PRION 2016, Tokyo, May 10-13, 2016
Presentations
1. Ae R, Nakamura Y, Takumi I, Sanjo N, Kitamoto T, Yamada M, Hamaguchi T, Tsukamoto T, Mizusawa H. Epidemiologic features of human prion disease in Japan: A prospective 15-year surveillance study. PRION 2016, Tokyo, May 10-13, 2016
2. Furukawa F, Sanjo N, Kobayashi A, Hamaguchi T, Yamada M, Kitamoto T, Mizusawa H, Yokota T. Differntial association of amyloid-β with PrPSc pathology in each genetic prion disease. PRION 2016, Tokyo, May 10-13, 2016
3. Hamaguchi T, Sakai K, Kitamoto T, Takao M, Murayama S, Iwasaki Y, Yoshida M, Shimizu H, Kakita A, Takahashi H, Suzuki H, Naiki H, Sanjo N, Mizusawa H, Yamada M. Cerebral beta-amyloidosis in patients with dura mater graft-associated Creutzfeldt-Jakob disease. PRION 2016, Tokyo, May 10-13, 2016 (Young Investigator Award)
4. Ishimura Y, Tsukamoto T, Kuwata K, Yamada M, Doh-ura K, Tsuboi Y, Sato K, Nakamura Y, Sanjo N, Tamura C, Mizusawa H. The Japanese consortium of prion disease (JACOP) for patient’s registration and clinical studies of prion diseases in Japan. PRION 2016, Tokyo, May 10-13, 2016
5. Iwasa K, Furukawa Y, Yoshikawa H, Yamada M. The partial loss and irregular overexpression of caveolin-3 in muscle cell membrane is detected in myasthenia gravis patients. 5th International Congress of Myology（Myology 2016）, Lyon, March 14-18, 2016
6. Kobayashi A, Parchi P, Yamada M, Brown P, Saverioni D, Matsuura Y, Takeuchi A, Mohri S, Kitamoto T. Iatrogenic transmission of Creutzfeldt-Jakob disease. PRION 2016, Tokyo, May 10-13, 2016
7. Komai K, Tagami A, Ishida C, Takahashi K, Motozaki Y, Yoshida M, Kirisaki H, Hitora T. Respiratory care support team improves respiratory management of inpatients with amyotrophic lateral sclerosis. The 15th Asian and Oceanian Congress of Neurology, KLCC, Kuala Lumpur, August 18-21, 2016
8. Komai K, Tagami A, Ishida C, Takahashi K, Motozaki Y, Akagi A, Ozaki T, Shimizu A, Yoshida M, Kirisaki H, Okano Y. Effectiveness of automatic intratracheal suctioning system for amyotrophic lateral sclerosis patients with tracheostomy-invasive ventilation. The 27th International Symposium on ALS/MND, Dublin, December 7-9, 2016
9. Komatsu J, Sakai K, Hamaguchi T, Sugiyama Y, Iwasa K, Yamada M. Creutzfeldt-Jakob disease associated with a V203I homozygous mutation in the prion protein gene. PRION 2016, Tokyo, May 10-13, 2016
10. Kuroiwa Y, Takumi I, Murai H, Kasuga K, Nakamura Y, Fujino K, Tanaka M, Kurosawa T, Baba Y, Sato K, Harada M, Kitamoto T, Tsukamoto T, Yamada M, Mizusawa H. Diagnostic significance of periodic synclonous discharges in Japanese surveillance of Creutzfeldt-Jakob disease. PRION 2016, Tokyo, May 10-13, 2016
11. Murai H, Nakamura Y, Kitamoto T, Tsuboi Y, Sanjo N, Yamada M, Mizusawa H, Kira J. Epidemiological survey of Gerstmann-Sträussler-Scheinker disease with codon 102 mutation in Japan. PRION 2016, Tokyo, May 10-13, 2016
12. Nakajima K, Komatsu J, Yoshita M, Samuraki M, Okuda K, Kinuya S, Yamada M. Differentiation of dementia with Lewy bodies and Alzheimer disease using standardized I-123 metaiodobenzylguanidine heart-ti-mediastinum ratio based on Japanese multicenter study. EANM’16, Barcelona, October 14-19, 2016
13. Nakamura K, Sakai K, Samuraki M, Nozaki I, Notoya M, Yamada M. Agraphia of Kanji (Chinise characters): An early symptom of sporadic Creutzfeldt-Jakob disease in a Japanese patient. PRION 2016, Tokyo, May 10-13, 2016
14. Sado T, Nishio A, Horita R, Yoshikawa H, Adachi Y, Matsuura K, Ikai S, Takada M, Hayashi F, Miyashita R, Yamamoto M. Attitudes toward Marriage and Parenthood among Japanese High School and University Students. The 6th Asian Congress of Health Psychology (ACHP 2016), Yokohama, July 23-24, 2016
15. Sakai K, Ikeda Y, Ishida C, Matsumoto Y, Ono K, Iwasa K, Yamada M. Inclusion body myositis with granuloma formation in muscle tissue. 5th International Congress of Myology（Myology 2016）, Lyon, March 14-18, 2016
16. Sakai K, Hamaguchi T, Sanjo N, Murai H, Shinohara M, Nozaki I, Nakamura Y, Kitamoto T, Mizusawa H, Yamada M. Diffusion-weighted images in patients with dura mater graft-associated Creutzfeldt-Jakob disease. PRION 2016, Tokyo, May 10-13, 2016
17. Sakai K, Boche D, Jonston D, Love S, Nicoll J. Aquaporin 4 and the response to Aβ immunotherapy in human Alzheimer’s disease. 5th International CAA Conference, Boston, September 8-10, 2016
18. Shima A, Sakai K, Hamaguchi T, Ikeda Y, Kitamoto T, Yamada M. Neuropathological analysis of hyperintense signals on magnetic resonance imaging in MM1+2 type sporadic Creutzfeldt-Jakob disease. PRION 2016, Tokyo, May 10-13, 2016
19. Takahashi K, Kakuda Y, Munemoto S, Yamazaki H, Nozaki I, Yamada M. Donor-derived macrophages in the central nervous system after umbilical cord blood stem cell transplantation. 10th FENS Forum, Copenhagen, July 2-6, 2016
20. Takumi I, Saito N, Sanjo N, Takayanagi S, Tamura C, Tsukamoto T, Kuroiwa Y, Ae R, Nakamura Y, Kitamoto T, Hamaguchi T, Yamada M, Kawada Y, Mizusawa H. CJD incidents in Japan. PRION 2016, Tokyo, May 10-13, 2016
21. Tsukamoto T, Ae R, Nakamura Y, Sanjo N, Kitamoto T, Satoh K, Hamaguchi T, Yamada M, Mizusawa H. Human prion diseases surveillance and registration system in Japan. PRION 2016, Tokyo, May 10-13, 2016
22. Yamada M, Hamaguchi T, Taniguchi Y, Sakai K, Kitamoto T, Takao M, Murayama S, Iwasaki Y, Yoshida M, Shimizu H, Kakita, Takahashi H, Suzuki H, Naiki H, Sanjo N, Mizusawa H. Possible iatrogenic transmission of cerebral amyloid antipathy and subpial Aβ deposition via cadaveric dura mater grafting. 5th International CAA Conference, Boston, September 8-10, 2016
23. Yoshita M, Odake Y, Ikeda M, Ichikawa S, Sakamoto H. Diagnostic accuracy of SPECT measurement of brain and heart in the differential diagnosis of Lewy body disease. The 3rd International Conference on heart & brain, Paris, February 25-27, 2016
24. Yoshita M, Odake Y, Ikeda M, Ichikawa S, Sakamoto H. A comparison of the diagnostic accuracy of MIBG, ECD and FP-CIT SPECT for detecting Lewy body disease in a memory clinic. Alzheimer’s Association International Conference (AAIC) 2016, Toronto, July 24-28, 2016
